|
- Bempedoic Acid: The Statin Alternative for Lowering Cholesterol
Learn how bempedoic acid lowers cholesterol without the muscle side effects of statins See who it's for, how it works, and clinical trial results
- 2022 ACC Expert Consensus Decision Pathway on the Role of . . .
The CLEAR Tranquility (Evaluation of the Efficacy and Safety of Bempedoic Acid [ETC-1002] as Add-on to Ezetimibe Therapy in Patients With Elevated LDL-C) and CLEAR Serenity (Evaluation of the Efficacy and Safety of Bempedoic Acid in Patients With Hyperlipidemia and Statin Intolerant) trials have demonstrated that monotherapy with bempedoic acid
- Bempedoic Acid: A Novel LDL Cholesterol–Lowering Agent
Bempedoic acid is an attractive adjunctive therapy for LDL cholesterol–lowering in adults Additionally, its design helps to avoid myalgia risk, and its oral administration makes it potentially easier to use than injectable PSCK9 inhibitors
- Efficacy of Bempedoic Acid, Novel Treatment for Elevated LDL . . .
In addition, bempedoic acid and statin combination therapy can be used for patients sensitive to high statin doses 6 Diagram of how bempedoic acid inhibits cholesterol synthesis within the liver Adapted from Rusisca et al
- Stepwise Approach to Novel Lipid-Lowering Medications
The article reviews the efficacy and safety of novel lipid-lowering agents, i e , proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitors, bempedoic acid, icosapent ethyl, evinacumab, and lomitapide The latter two are indicated for management of homozygous familial hypercholesterolemia
- Bempedoic acid in the management of lipid disorders and . . .
Bempedoic acid, the first in-class inhibitor of ATP-citrate lyase presents a new approach to lipid-lowering therapy By reducing the endogenous production of cholesterol, upstream of the rate-limiting enzyme HMG-CoA-reductase, i e , the target of statins, bempedoic acid reduces circulating plasma concentrations of low-density lipoprotein cholesterol (LDL-C), and major adverse CVD events (MACE
- PATIENT-CENTERED EDUCATION FROM THE NATIONAL LIPID . . .
Bempedoic acid interferes with an enzyme in the liver that regulates cholesterol production It allows for increased clearance of LDL-C from the blood stream leading to lower levels Bempedoic acid is only active within the liver cells and not in skeletal muscle Therefore, it can be used in patients who have had prior statin associated muscle symptoms
- (PDF) Bempedoic Acid: A Novel Approach in Managing . . .
This review concludes that bempedoic acid represents a significant advancement in lipid-lowering therapy, offering a valuable option for patients with hypercholesterolemia, particularly those with
|
|
|